[News Brief] Repurposed Antibiotic Shows Potential in CNS Tuberculosis Research
A study by researchers at NUS Medicine has shown that the antibiotic doxycycline, when added to standard treatment in laboratory…
Pharmaceuticals & Supplements
[News Brief] Vietnam Clarifies Regulatory Oversight Under New Law on Chemicals
Vietnam has issued Decree No. 26/2026/ND-CP to clarify the implementation of its 2025 Law on Chemicals, specifically assigning regulatory authority…
[News Brief] Chinese Medicines Increasingly Reach Global Health Market
A report from China’s State Council Information Office shows that Chinese-made medicines and medical devices are gaining a stronger foothold…
[News Brief] C&R Research Strengthens Clinical Trial Capabilities in Indonesia
C&R Research, a South Korean contract research organisation (CRO), is expanding its clinical trial operations in Indonesia as part of…
[News Brief] HSA Revises Registration Guidelines for Therapeutic Products
The Health Sciences Authority (HSA) has updated its regulatory guidance for the registration of therapeutic products to improve efficiency and…
[News Brief] HSA Updates Regulatory Guidelines for Software Medical Devices
The Health Sciences Authority (HSA) has released Revision 4 of the GL-04 guidelines, introducing updated regulatory expectations for software medical…
[News Brief] A*STAR GIS and 10x Genomics Launch TISHUMAP Study
The A*STAR Genome Institute of Singapore (GIS) and 10x Genomics have launched the Target Inference from Spatialomics & Histology Using…
[News Brief] PRECISE Partners with Global Firms for Asian Precision Medicine
Precision Health Research, Singapore (PRECISE) has established a partnership with Alnylam, Bayer, Boehringer Ingelheim, and Novo Nordisk to advance precision…
[News Brief] Kerry Releases 2026 Supplement Taste Charts
Kerry has published its 2026 Taste Charts, identifying emerging flavour trends for the supplements and sports nutrition sectors. This summary…
[News Brief] GSK Receives Japanese Approval for Depemokimab
Japan’s Ministry of Health, Labour and Welfare has approved GSK’s depemokimab (Exdensur) as an add-on treatment for certain types of…